Lexology December 5, 2024
Health care continues to drive private equity (“PE”) activity, creating opportunities for investors and traditional health care providers. Transactions in the health care space are especially complicated, layering health care regulatory and reimbursement considerations on top of a complex securities, antitrust, privacy and security framework.
Hall Render’s PE team of attorneys and advisors leverage the strength and depth of our bench to navigate and efficiently execute PE transactions. The summary below includes highlights of recent PE deals and legislative updates.
- CVC Capital Partners completed an acquisition of Therakos, Inc. from Mallinckrodt Pharmaceuticals for a purchase price of $925 million. Therakos specializes in extracorporeal photopheresis delivery systems for use around the world, used to treat immune-related diseases. CVC aims to...
Today's Sponsors
Today's Sponsor